News About: Pharm. Industry
Foreign GMP inspection to be expanded, KFDA officials say
The Korea Food and Drug Administration will strengthen its on-spot inspection on foreign GMP facilities as part of efforts to ensure the quality of medicinal products.
So far, the KFDA has conducted its on-spot ins...
Multinationals are likely to leave Korea
Korea will face an exodus of foreign-invested pharmaceutical firms operating here, as many are complaining about the government’s unilateral assessment of conventional medicines and price cut, causing a sharp drop in ...
Hydrogel wound dressing market warming up
The domestic market is gaining momentum with a new comer 3M who sees opportunities in the field where larger companies are rushing into the game after the market success by Ildong’s Medifoam in 2003.
3M says its Te...
Korean drug companies urged to explore overseas markets
Korean pharmaceutical firms should look to advance into overseas market, amid the government’s relentless price cut and fiercer competition in already saturated domestic market, according to a local analyst.
Analys...
CJ breaks ground for cGMP plantA ground-breaking ceremony for construction of a new cGMP plant was held in Osung complex of North Chungcheong Province on July 15, according to CJ Cheiljedang.
CJ said it w...
|
Prices of OTC brand items on upward trend
The prices of renowned brand items, including Urusa, are rising, fueled by the continuing upward spiral of international oil prices and raw material prices.
Furthermore, some manufacturers have scrapped premiums of...
Intense competition foreseeable in domestic antipsychotic market
The local antipsychotic market will become fierce, as the future outlook for AstraZeneca’s Seroquel (quetiapine fumarate) is expected to be cloudy by numerous generic drug manufacturers including Whanin Pharm, who lau...
Hectic year forecast for M&As
The mergers and acquisitions market is expected to heat up this year as a number of pharmaceutical firms vows to speed up the takeover bid of promising biopharmaceutical companies.
Major pharmaceutical firms, hung...
Price of Lamisil Once to rise 15%
Pacific Pharm says the price of Lamisil once cutaneous solution will rise 15 percent from July 16 due to the recent drastic hike of euro against Korean won.
Developed by Switzerland based Novartis, Lamisil once con...
KPMA to adopt FKI-style advisory member system
The Korea Pharmaceutical Manufacturers Association needs to create a strong advisory group consisting of influential chief executive officers as demonstrated in the Federation of Korean Industries.
Both the FKI’s c...
